Safety and Efficacy of Ticagrelor with Aspirin DAPT vs. Aspirin Alone in Patients Undergoing CABG Following ACS: A Systematic Review and Meta-Analysis

Kunal Mahajan, Deep Dutta, A.B.M. Kamrul-Hasan, Nitin Mahajan, Jaibharat Sharma, Surender Himral, Shekhar Vohra, Akshyaya Pradhan

Open source

DOI
10.2174/011871529x488257260710041631
Published
2026-07-17
Container
Cardiovascular & Hematological Disorders-Drug Targets
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/011871529x488257260710041631,
  title = {Safety and Efficacy of Ticagrelor with Aspirin DAPT vs. Aspirin Alone
in Patients Undergoing CABG Following ACS: A Systematic Review and
Meta-Analysis},
  author = {Kunal Mahajan and Deep Dutta and A.B.M. Kamrul-Hasan and Nitin Mahajan and Jaibharat Sharma and Surender Himral and Shekhar Vohra and Akshyaya Pradhan},
  year = {2026},
  journal = {Cardiovascular \& Hematological Disorders-Drug Targets},
  doi = {10.2174/011871529x488257260710041631},
  url = {https://doi.org/10.2174/011871529x488257260710041631}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of Ticagrelor with Aspirin DAPT vs. Aspirin Alone
in Patients Undergoing CABG Following ACS: A Systematic Review and
Meta-Analysis
AU  - Kunal Mahajan
AU  - Deep Dutta
AU  - A.B.M. Kamrul-Hasan
AU  - Nitin Mahajan
AU  - Jaibharat Sharma
AU  - Surender Himral
AU  - Shekhar Vohra
AU  - Akshyaya Pradhan
PY  - 2026
JO  - Cardiovascular & Hematological Disorders-Drug Targets
DO  - 10.2174/011871529x488257260710041631
UR  - https://doi.org/10.2174/011871529x488257260710041631
ER  - 

APA

Mahajan, K., Dutta, D., Kamrul-Hasan, A., Mahajan, N., Sharma, J., Himral, S., Vohra, S., & Pradhan, A. (2026). Safety and Efficacy of Ticagrelor with Aspirin DAPT vs. Aspirin Alone in Patients Undergoing CABG Following ACS: A Systematic Review and Meta-Analysis. Cardiovascular & Hematological Disorders-Drug Targets. https://doi.org/10.2174/011871529x488257260710041631

Source records